Richy, F., Rabenda, V., Mawet, A., & Reginster, J.-Y. (August 2007). Flurbiprofen in the symptomatic management of rheumatoid arthritis: a valuable alternative. International Journal of Clinical Practice, 61 (8), 1396-1406. doi:10.1111/j.1742-1241.2007.01452.x Peer Reviewed verified by ORBi |
Richy, F., Bruyère, O., Mawet, A., & Reginster, J.-Y. (June 2006). Prescription and coprescription patterns of bone-active substances among postmenopausal women. Osteoporosis International, 17 (Suppl.2), 60. Peer Reviewed verified by ORBi |
Richy, F., Bruyère, O., Mawet, A., & Reginster, J.-Y. (March 2006). Prescription and coprescription patterns of bone-active substances among postmenopausal women. Osteoporosis International, 17 (Suppl.1), 93. Peer Reviewed verified by ORBi |
Richy, F., Deroisy, R., Lecart, M.-P., Hanssens, L., Mawet, A., & Reginster, J.-Y. (April 2005). D-Hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management. Aging Clinical and Experimental Research, 17 (2), 133-142. doi:10.1007/BF03324586 Peer Reviewed verified by ORBi |
Richy, F., Ethgen, O., Bruyère, O., Mawet, A., & Reginster, J.-Y. (December 2004). Primary prevention of osteoporosis: Mass screening scenario or prescreening with questionnaires? An economic perspective. Journal of Bone and Mineral Research, 19 (12), 1955-1960. doi:10.1359/JBMR.040903 Peer Reviewed verified by ORBi |